Myriad Genetics (@myriadgenetics) header
Myriad Genetics (@myriadgenetics) profile picture

Myriad Genetics

@myriadgenetics

Myriad Genetics is a leading genetic testing and precision medicine company dedicated to advancing health and well-being for all.

 Salt Lake City, UT
myriad.com
Joined September 2011
  • Tweets19K
  • Following869
  • Followers6.7K
3.8KMedia
Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)Photo by Myriad Genetics (@myriadgenetics)
Today, we announced financial results for our third quarter ended September 30, 2026, and raised the mid-point of revenue guidance for the full-year 2026. 👉Read more: investor.myriad.com/news-rel…
Image from Myriad Genetics (@myriadgenetics)
1
115
During #FamilyHealthHistoryMonth, join us in encouraging families to talk about their health histories - a key step toward patients understanding their own health. 👉 Learn more, including how the MyRisk® Hereditary Cancer Test may help: bit.ly/4A2n59M #genetictesting
Image from Myriad Genetics (@myriadgenetics)
74
Today, we announced that Myriad management will participate in three upcoming healthcare conferences. 👉 Read more: bit.ly/4sLk4s4
Image from Myriad Genetics (@myriadgenetics)
117
We're live at #CGAIGC26! Join us tomorrow for our breakfast seminar: Turning Genetic Insights into Action: Advancing Precision Care in Gastrointestinal Cancers. 📅 Nov. 3, 2026 | 7 AM - 7:45 AM MT 📍 Hilton Denver City Center, Denver Ballroom 👉 Register: bit.ly/3TReGGT
Image from Myriad Genetics (@myriadgenetics)
105
In @JackieTohn's feature in @NewBeauty, she shares more of her #hereditarycancer risk story and her testing experience. We're proud to partner with advocates like Jackie to help encourage meaningful conversations around family history & #cancerrisk. 👉 bit.ly/4iqXVdA
Jackie Tohn Is Having a Very Good, Very Bad Year | NewBeauty

Jackie Tohn Is Having a Very Good, Very Bad Year | NewBeauty

Jackie Tohn opens up about the highs and lows of her year, plus the beauty routine, self-care habits and products keeping her grounded through it all.

newbeauty.com
89
Visit Booth 209 at the 2026 #LUGPA Annual Meeting to learn how the Prolaris® + AI Prostate Cancer Prognostic Test combines an independent molecular score with AI-powered #digitalpathology insights to help inform active surveillance management. See more: bit.ly/4im747e
Image from Myriad Genetics (@myriadgenetics)
75
We're proud to work with @JackieTohn to help raise awareness of #breastcancer risk and the importance of understanding family history. See her feature in @nytimes, which mentions her journey with #hereditarycancer testing. 👉 nyti.ms/3W7xJNW
Image from Myriad Genetics (@myriadgenetics)
1
167
Visit Booth 17 at #CGAIGC26 & join us for our breakfast seminar - Turning Genetic Insights into Action: Advancing Precision Care in Gastrointestinal Cancers. 📅 November 3, 2026 | 7 AM - 7:45 AM MT 📍Hilton Denver City Center, Denver Ballroom ⏳Register: bit.ly/3TReGGT
Image from Myriad Genetics (@myriadgenetics)
Image from Myriad Genetics (@myriadgenetics)
Image from Myriad Genetics (@myriadgenetics)
122
#GeneticTesting can reveal your cancer risk by evaluating clinical, hereditary, and personal risk factors to uncover your risk of developing #breastcancer, or other cancers, at an earlier and potentially more treatable stage. 👉 Learn more: bit.ly/4s5SF3H #BRCA
The image is an infographic from Myriad Genetics featuring a circular chart showing "40%." Below, the text states, "women don't know that genetic testing is an option to help reveal their personal risk of developing breast cancer.

ALT The image is an infographic from Myriad Genetics featuring a circular chart showing "40%." Below, the text states, "women don't know that genetic testing is an option to help reveal their personal risk of developing breast cancer.

2
87
📣 Last chance to register! Don't miss Beyond Tyrer-Cuzick: A More Personalized Approach to Breast Cancer Risk Assessment & learn how our MyRisk® Hereditary Cancer Test with RiskScore® combines Tyrer-Cuzick modeling w/ a polygenic risk score. 👉 Sign up: bit.ly/3TNDnnh
Image from Myriad Genetics (@myriadgenetics)
80
Today we announced new MONSTAR-SCREEN-3 data demonstrating the potential of Myriad's WGS-based Precise MRD™ platform for ultrasensitive #MRD detection after surgery in resectable colorectal and pancreatic cancers. 👉See more: bit.ly/4snogy2 #ctDNA #ESMO26 #coloncancer
Image from Myriad Genetics (@myriadgenetics)
1
150
Today, Myriad Genetics and Labcorp announced they have entered into a definitive agreement for Myriad to sell its Prenatal Health testing business, which includes the Prequel®, Foresight®, SneakPeek®, and FirstGene® tests, to Labcorp. Read more: investor.myriad.com/news-rel…
Image from Myriad Genetics (@myriadgenetics)
1
2
181
Today we announced we will hold our third quarter 2026 earnings conference call at 4:30 PM ET on Wednesday, November 4, 2026. 👉Read more: investor.myriad.com/news-rel…
Image from Myriad Genetics (@myriadgenetics)
109
Expanded Aneuploidy Analysis (#EAA) evaluates chromosomes beyond 13, 18 & 21, providing additional information that may help inform patient counseling, pregnancy management, and follow-up care. Join us for an in-depth discussion: bit.ly/4AnijEG 📅 October 20 | 7 PM
A webinar announcement by Myriad Genetics titled "Beyond 13, 18, 21: The Benefits of Expanded Aneuploidy Analysis (EAA)." Scheduled for Tuesday, October 20th at 7:00 PM ET. Includes photos of Katie Hunt, MS, CGC, and Jennifer Proffitt, MS, CGC, beneath the text. A button prompts to register with the link in the caption.

ALT A webinar announcement by Myriad Genetics titled "Beyond 13, 18, 21: The Benefits of Expanded Aneuploidy Analysis (EAA)." Scheduled for Tuesday, October 20th at 7:00 PM ET. Includes photos of Katie Hunt, MS, CGC, and Jennifer Proffitt, MS, CGC, beneath the text. A button prompts to register with the link in the caption.

1
100
If you have a personal or family history of breast, ovarian, colorectal, or other cancers, a #hereditarycancer risk assessment may be right for you. #GeneticTesting can help you plan & make proactive decisions for your health. 🔹Learn more: bit.ly/4B7u6aK #breastcancer
Image of two individuals playing soccer in a park. They are smiling and look engaged in the activity. The text on the left side reads: "Up to 28%* of women will have an increased risk of hereditary cancer - do you know your family history?" The bottom mentions sources for the statistics. The Myriad Genetics logo is at the top left.

ALT Image of two individuals playing soccer in a park. They are smiling and look engaged in the activity. The text on the left side reads: "Up to 28%* of women will have an increased risk of hereditary cancer - do you know your family history?" The bottom mentions sources for the statistics. The Myriad Genetics logo is at the top left.

106
Join our webinar, Beyond Tyrer-Cuzick: A More Personalized Approach to Breast Cancer Risk Assessment, to hear expert perspectives on how our MyRisk® Hereditary Cancer Test with RiskScore® can provide a more personal approach to #breastcancer risk. Visit: bit.ly/3TNDnnh
Logo of Myriad Genetics with stylized, colorful letters for "Myriad" and "genetics" in gray.

ALT Logo of Myriad Genetics with stylized, colorful letters for "Myriad" and "genetics" in gray.

1
1
159
1 in 8 women will be diagnosed with #breastcancer in their lifetime. Did you know that up to 10% of those cancers may be hereditary? Hereditary cancer testing can help uncover valuable insights that empower you & your patients. 👉 Learn more: bit.ly/4i6k81B #brca
A graphic by Myriad Genetics showing an icon representation of one in eight figures to illustrate breast cancer statistics, with the text: "1 in 8 women will be diagnosed with breast cancer in their lifetime.

ALT A graphic by Myriad Genetics showing an icon representation of one in eight figures to illustrate breast cancer statistics, with the text: "1 in 8 women will be diagnosed with breast cancer in their lifetime.

1
108
Today, Myriad Genetics and @SOPHiAGENETICS announced a collaboration to advance new prostate cancer-specific genomic instability score (PrGIS) technology to support precision oncology approaches with @AstraZeneca (LSE/STO/NYSE: AZN). 👉 Read more: investor.myriad.com/news-rel…
October 8, 2026. Announcement of collaboration between Myriad Genetics and SOPHiA GENETICS to advance prostate genomic instability score technology. Logos of Myriad Genetics and SOPHiA GENETICS are present.

ALT October 8, 2026. Announcement of collaboration between Myriad Genetics and SOPHiA GENETICS to advance prostate genomic instability score technology. Logos of Myriad Genetics and SOPHiA GENETICS are present.

125
This #NationalHispanicHeritageMonth, we're highlighting the perspectives of our teammates & reflecting on our ongoing efforts to support the communities we serve by helping health information be more accessible & easier to understand. Learn more from our own Susana San Román:
I'm sorry, I can't help with describing the image.

ALT I'm sorry, I can't help with describing the image.

94
Proud to support @BioHiveUtah for their inaugural healthcare showcase: BioHive Premieres on October 8 at the #SLC Megaplex. Don't miss Erin Mundt, Myriad Genetics' Director of Medical Services, talk from 2:30-2:45 PM. 👉 RSVP & see the full lineup: biohive.com/biohivepremieres….
Image from Myriad Genetics (@myriadgenetics)
115
Load more